S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q4 2024

Avoro Capital Advisors

Period: Q4 2024 Β· Filed: 2025-02-14
View on SEC EDGAR β†—
AUM
$7.07B
Total portfolio value
Positions
39
Reported securities
Top Holding
UTHR
13.8% $973.9M
QoQ Changes
+7 / -4
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
UTHRUNITED THERAPEUTICS CORP$973.9M13.78%$352.84$555.91+57.5%
13.8%
ARGXARGENX SE$761.7M10.77%$615.00$939.68+52.8%
10.8%
ASNDASCENDIS PHARMA$702.5M9.94%$137.67$274.50+99.4%
9.9%
MDGLMADRIGAL PHARMACEUTICALS INC$626.1M8.86%$308.57$528.10+71.1%
8.9%
KRYSKRYSTAL BIOTECH INC$411.8M5.83%$156.66$375.07+139.4%
5.8%
APLSAPELLIS PHARMACEUTICALS INC.$390.0M5.52%$31.91β€”
5.5%
SRPTSAREPTA THERAPEUTICS INC$310.7M4.40%$121.59$19.28-84.1%
4.4%
ITCIINTRA-CELLULAR THERAPIES INC$254.7M3.60%β€”β€”
3.6%
VERAVERA THERAPEUTICS INC$237.3M3.36%$42.29$41.20-2.6%
3.4%
XENEXENON PHARMACEUTICALS INC$222.1M3.14%$39.20$60.96+55.5%
3.1%
FOLDAMICUS THERAPEUTICS INC.$218.3M3.09%β€”β€”
3.1%
RNAMAVIDITY BIOSCIENCES INC$218.1M3.08%β€”β€”
3.1%
ARWRARROWHEAD PHARMACEUTICALS INC.$208.9M2.95%$18.80$83.99+346.8%
3.0%
KYMRKYMERA THERAPEUTICS INC$207.2M2.93%$40.23$113.51+182.2%
2.9%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$150.0M2.12%$54.15$18.95-65.0%
2.1%
SLNOSOLENO THERAPEUTICS INC$113.5M1.61%$44.95β€”
1.6%
BPMCBLUEPRINT MEDICINES CORP$103.4M1.46%β€”β€”
1.5%
PCVXVAXCYTE INC$96.2M1.36%$81.86$58.39-28.7%
1.4%
BMRNBIOMARIN PHARMACEUTICAL INC$96.1M1.36%$65.73$58.99-10.3%
1.4%
MRUSMERUS N V$89.4M1.26%β€”β€”
1.3%
BCRXBIOCRYST PHARMACEUTICALS INC$89.2M1.26%$7.52$9.84+30.9%
1.3%
ALKSALKERMES PLC$70.5M1.00%$28.76$54.58+89.8%
1.0%
OCULOCULAR THERAPEUTIX INC$68.8M0.97%$8.54$9.64+12.9%
1.0%
MNKDMANNKIND CORP$56.3M0.80%$6.43$4.52-29.7%
0.8%
TRMLTOURMALINE BIO INC$45.1M0.64%β€”β€”
0.6%
QUREUNIQURE NV$38.4M0.54%$17.66$41.81+136.8%
0.5%
RAREULTRAGENYX PHARMACEUTICAL INC$34.9M0.49%$42.07$33.47-20.4%
0.5%
TSHATAYSHA GENE THERAPIES INC$34.6M0.49%$1.73$6.53+277.5%
0.5%
ETNB89BIO INC$32.1M0.45%β€”β€”
0.5%
GLUEMONTE ROSA THERAPEUTICS INC$30.1M0.43%$6.94$24.21+248.8%
0.4%

Quarter-on-Quarter Activity

Q4 2024 vs. Q3 2024

New Positions (7)

TickerIssuerNotionalSince Filing
BPMCBLUEPRINT MEDICINES CORP$103.4M
ALKSALKERMES PLC$70.5M+89.8%
QUREUNIQURE NV$38.4M+136.8%
ETNB89BIO INC$32.1M
SEPNSEPTERNA INC$25.4M
RCKTROCKET PHARMACEUTICALS INC$15.1M
OLMAOLEMA PHARMACEUTICALS INC$9.6M

Exited Positions (4)

TickerIssuerNotional
DYNDYNE THERAPEUTICS INC.$23.4M
SYRESPYRE THERAPEUTICS INC$17.6M
NGNENEUROGENE INC$0.9M
INSMED INC$0.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
MRUSMERUS N V$21.7M+56.8%
VERAVERA THERAPEUTICS INC$46.8M+30.2%-2.6%
ARWRARROWHEAD PHARMACEUTICALS INC.$36.7M+25.0%+346.8%
SLNOSOLENO THERAPEUTICS INC$3.4M+15.8%
KYMRKYMERA THERAPEUTICS INC$-5.8M+14.4%+182.2%
APLSAPELLIS PHARMACEUTICALS INC.$69.6M+10.0%
RNAMAVIDITY BIOSCIENCES INC$-97.7M+9.1%
TSHATAYSHA GENE THERAPIES INC$-2.9M+7.2%+277.5%

Trimmed (7)

TickerIssuerNotionalShares Ξ”Since Filing
SNDXSYNDAX PHARMACEUTICALS INC$-44.8M-41.5%
KURAKURA ONCOLOGY INC$-49.6M-36.5%
BMRNBIOMARIN PHARMACEUTICAL INC$-47.1M-28.2%-10.3%
GLUEMONTE ROSA THERAPEUTICS INC$-0.5M-25.0%+248.8%
AUTLAUTOLUS THERAPEUTICS PLC$-21.5M-19.7%
IOVAIOVANCE BIOTHERAPEUTICS INC$-13.9M-17.5%
UTHRUNITED THERAPEUTICS CORP$-50.5M-3.4%+57.5%
← Back to Hedge Funds